In vitro and in vivo activity of a novel c-Met-targeting antibody-drug conjugate using a DNA-alkylating, indolinobenzodiazepine payload

被引：7
|
作者：
Lai, Katharine C.
Muvaffak, Asli
Li, Min
Themeles, Marian
Sikka, Surina
Donahue, Kerry
Hicks, Stuart W.
Romanelli, Angela
Chittenden, Thomas
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-45
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
45
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
    Jin, Yangbing
    Zhang, Zehui
    Zou, Siyi
    Li, Fanlu
    Chen, Hao
    Peng, Chenghong
    Deng, Xiaxing
    Wen, Chenlei
    Shen, Baiyong
    Zhan, Qian
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] In vitro and in vivo activity of a site-specific SeriMab antibody-drug conjugate (ADC) using an indolino-benzodiazepine DNA-alkylating agent
    Vitharana, Dilrukshi
    Wilhelm, Alan
    Harris, Luke
    Archer, Katie
    Shizuka, Manami
    Maloney, Erin
    Ab, Olga
    Laleau, Rassol
    Sun, Xiuxia
    Pinkas, Jan
    Miller, Michael
    Chari, Ravi
    Keating, Thomas
    Fishkin, Nathan
    CANCER RESEARCH, 2016, 76
  • [3] Preclinical evaluation of M-DGN549, a folate receptor alpha-targeting antibody-drug conjugate (ADC) with a DNA-alkylating payload
    Setiady, Y.
    Lanieri, L.
    Ab, O.
    Maloney, E.
    Hong, E.
    Qiu, Q.
    Zhou, Y.
    Zhao, J.
    Themeles, M.
    Zhang, X.
    Pinkas, J.
    Soto, R. Ruiz
    Ponte, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S145 - S145
  • [4] IMGN779, a Novel CD33-Targeting Antibody-Drug Conjugate with DNA-Alkylating Activity, Exhibits Potent Antitumor Activity in Models of AML
    Kovtun, Yelena
    Noordhuis, Paul
    Whiteman, Kathleen R.
    Watkins, Krystal
    Jones, Gregory E.
    Harvey, Lauren
    Lai, Katharine C.
    Portwood, Scott
    Adams, Sharlene
    Sloss, Callum M.
    Schuurhuis, Gerrit Jan
    Ossenkoppele, Gert
    Wang, Eunice S.
    Pinkas, Jan
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (06) : 1271 - 1279
  • [5] Synthesis of Highly Potent N-10 Amino-Linked DNA-Alkylating Indolinobenzodiazepine Antibody-Drug Conjugates (ADCs)
    Archer, Katie E.
    Reid, Emily E.
    Shizuka, Manami
    Woods, James
    Harris, Luke
    Maloney, Erin K.
    Bartle, Laura M.
    Ab, Olga
    Wilhelm, Alan
    Setiady, Yulius
    Ponte, Jose F.
    Singh, Rajeeva
    Keating, Thomas A.
    Chari, Ravi V. J.
    Miller, Michael L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (08): : 1211 - 1215
  • [6] IMGN632: A CD123-Targeting Antibody-Drug Conjugate (ADC) with a Novel DNA-Alkylating Payload, Is Highly Active and Prolongs Survival in Acute Myeloid Leukemia (AML) Xenograft Models
    Adams, Sharlene
    Wilhelm, Alan
    Harvey, Lauren
    Bai, Chen
    Yoder, Nicholas
    Kovtun, Yelena
    Chittenden, Thomas
    Pinkas, Jan
    BLOOD, 2016, 128 (22)
  • [7] Antibody-drug conjugates (ADCs) with a novel DNA-alkylating agent, DGN462, are highly potent in vitro and in vivo against human cancer models
    Whiteman, Kathleen
    Audette, Charlene
    Dandeneau, Andre
    Ellis, Megan
    Fishkin, Nathan
    Harvey, Lauren
    Johnson, Holly
    Kovtun, Yelena
    Maloney, Erin
    Miller, Michael
    Wilhelm, Alan
    Chari, Ravi
    CANCER RESEARCH, 2014, 74 (19)
  • [8] First-in-human study of ABBV-400, a novel c-Met-targeting antibody-drug conjugate, in advanced solid tumors: Results in colorectal cancer
    Sharma, Manish
    Strickler, John H.
    Sommerhalder, David
    Kuboki, Yasutoshi
    Perets, Ruth
    Cohen, Jonathan
    Raimbourg, Judith
    Nakajima, Takako Eguchi
    Yamamoto, Noboru
    Cruz-Correa, Marcia
    O'Neil, Bert
    Ghiringhelli, Francois
    Raghav, Kanwal Pratap Singh
    Li, Rui
    Thiele, Gladys Morrison
    Aristide, Martha Raluca Neagu
    Freise, Kevin Jay
    de Almeida, Carla Biesdorf
    Vasilopoulos, Athanasios
    Powderly, John D., II
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] MI130004, an antibody-drug conjugate including a novel payload of marine origin: Evidences of in vivo activity
    Aviles, P. M.
    Guillen, M. J.
    Dominguez, J. M.
    Munoz-Alonso, M. J.
    Garcia-Fernandez, L. F.
    Garranzo, M.
    Martinez, V.
    Francesch, A.
    Munt, S.
    Galmarini, C. M.
    Cuevas, C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 164 - 164
  • [10] Preclinical Development of a Bcma Targeting Antibody-Drug Conjugate with Novel Payload for Multiple Myeloma Therapy
    Hau, Andrew
    Zhu, Tong
    Wang, Rengang
    Lau, Megan
    Li, Lingna
    Li, Xiaoqing
    Sun, Yingqing
    Kovacs, Ernest
    Khasanov, Alisher
    Deng, Dalun
    Yan, Zheng
    Knight, Robert D.
    Kaufmann, Gunnar F.
    Ji, Henry
    Li, Hui
    Zhang, Hong
    BLOOD, 2019, 134
12345